Browsing: biopharma nl

Regulatory pressure is mounting on Amgen’s inflammatory disorder drug, Tavneos, with the European Medicines Agency recommending revocation of the product’s…

A metabolic disorder that leads to high levels of fat in the blood and life-threatening pancreatic complications now has its…

Earlier this year,  the FDA announced a breakthrough that could fundamentally transform how medical evidence reaches patients. For the first…

The FDA has expanded the approval of a targeted Gilead Sciences therapy as a new first-line treatment for triple-negative breast…

One of the most challenging aspects of treating many diseases, including cancer and inflammatory conditions, is that they are highly…

After a few lackluster years, biotech IPOs have rebounded in 2026. A new record for the most cash raised by…

At a time where vaccine skepticism is growing and the childhood vaccine schedule updated in January, vaccine manufacturers are running…

As a Sanofi veteran, Frédéric Marrache is well aware of the innovations shaping immunology. His tenure there came as Dupixent…

Investment in AI-driven drug discovery continues to grow, reflecting how strongly the industry believes faster in silico discovery can reshape…